Prostate Cancer: New serum tumor marker for monitoring patients.
As the incidence of prostatic cancer rises, family physicians can expect to diagnose and treat increasing numbers of patients with this disease. Recent research has uncovered a new serum tumor marker (prostate-specific antigen), which is useful in patient monitoring and which eventually could be used in screening. A current review of available serum tumor markers is presented.